IMMUNE-MEDIATED HEPATITIS
Clinical trials for IMMUNE-MEDIATED HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-MEDIATED HEPATITIS trials appear
Sign up with your email to follow new studies for IMMUNE-MEDIATED HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer treatment breakthrough? gentler steroid dose fights dangerous liver side effect
Disease control Recruiting nowThis study is testing if a lower, gentler dose of steroids can safely treat liver inflammation that sometimes occurs as a side effect of powerful cancer immunotherapies. It will involve about 63 adult cancer patients who develop this specific liver issue. The goal is to see if th…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists hunt for clues to pinpoint cancer Drug's liver side effects
Knowledge-focused Recruiting nowThis study aims to find specific markers in the blood that can tell the difference between liver inflammation caused by cancer immunotherapy drugs and other types of autoimmune liver disease. Researchers will compare blood samples from 60 adults with these conditions. The goal is…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists hunt for clues to stop dangerous side effect of cancer drugs
Knowledge-focused Recruiting nowThis study aims to understand why some cancer patients develop liver injury after taking immunotherapy drugs called checkpoint inhibitors. Researchers will observe 160 patients who either develop this liver injury or are starting the drugs, collecting blood samples to look for bi…
Matched conditions: IMMUNE-MEDIATED HEPATITIS
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC